References
- Sen M, Honavar SG. After the storm: ophthalmic manifestations of COVID-19 vaccines. Indian J Ophthalmol. 2021;69(12):3398–3420. doi:10.4103/ijo.IJO_2824_21.
- Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. OculImmunolInflamm. 2021;29:730–733.
- Ng XL, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. OculImmunolInflamm. 2021;29(6):1216–1224.
- Testi I, Brandão-de-resende C, Agrawal R, Pavesio C. COVID-19 vaccination ocular inflammatory events study group. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12(1):4. doi:10.1186/s12348-021-00275-x.
- Lee C, Park KA, Ham DI, et al. Neuroretinitis after the second injection of a SARS-CoV-2-vaccine: a case report. Am J Ophthalmol Case Rep. September 2022;27:101592. doi:10.1016/j.ajoc.2022.101592.
- García-Estrada C, Gómez-Figueroa E, Alban L. Arias-Cárdenas a optic neuritis after COVID-19 vaccine application. ClinExpNeuroimmunol. November 2021;22:10.
- Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21(4):195–197. doi:10.1038/s41577-021-00526-x.
- Kanduc D, Shoenfeld Y. On the molecular determinants of the SARS-CoV-2 attack. Clin Immun. 2020;215:108426. doi:10.1016/j.clim.2020.108426.